Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Positron

This article was originally published in The Gray Sheet

Executive Summary

Positron: President and CEO Werner Haas, PhD, resigns, the firm announced in an April 11 release. Chairman of the Board Gary Wood has assumed Haas' duties. The Houston firm is "currently experiencing liquidity problems" and "has recently been unable to pay certain of its obligations within their standard payment date," according to the release. Additionally, Positron's pending acquisition of GE Medical Systems' positron emission tomography assets ("The Gray Sheet" July 22, 1996, I&W-5) has been "delayed." Although the two firms remain in negotiations over the deal, GEMS is free to negotiate with other companies because the transaction did not close by March 31, Positron notes...

You may also be interested in...



Cybersecurity: Guidance Docs To Come, But Legacy Devices Still A Challenge

Increasing savvy around cybersecurity issues is driving regulators and trade groups to update their approach to the area, speakers from the US FDA and the American Medical Association said at this week’s FDA/CMS Summit.

Majority Of Spanish OTC Firms Investing Heavily In Digital

A recent ANEFP survey shows that the majority of Spanish OTC firms consider their digital strategies to be "very advanced."

Recent And Upcoming FDA Advisory Committee Meetings

Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.

UsernamePublicRestriction

Register

MT007964

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel